We recently published a list of 12 AI Updates Worth Taking a Look At. In this article, we are going to take a look at where ...
Nvidia (NASDAQ:NVDA) is in the spotlight ahead of its Q4 earnings, with Evercore ISI and Piper Sandler sticking to their ...
Evercore ISI says the firm would be buyers of Nvidia (NVDA) into the company’s January quarter earnings call scheduled for February 26. While ...
Evercore (NYSE: EVR) will host its 2nd annual Private Markets Forum in New York City on March 11-12, 2025. This year’s event will host executives and industry experts from over 20 leading private ...
Nvidia (NVDA) was in focus on Tuesday as investment firms Evercore ISI and Piper Sandler issued positive notes on the ...
Evercore ISI analyst Amit Daryanani maintained a Buy rating on Dell Technologies (DELL – Research Report) yesterday and set a price target of ...
Trump directed a US agency to limit Chinese spending on technology and other strategic US sectors. Read more at ...
14hon MSN
Julian Emanuel, Evercore ISI senior managing director, joins 'Fast Money' to talk the impact of tariffs, uncertainty, and ...
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results